Big Oil Earnings Season Marks A Return To Basics With Lower Profits — Neutral

XOM   Forbes — November 10, 2025

The ‘Big Oil' quarterly earnings season ended last week, as one energy major after another posted relatively lower profits compared to bumper ones from three years ago. But there was one other commonality between them all - a clear and firm return to oil and gas basics.

image for news Big Oil Earnings Season Marks A Return To Basics With Lower Profits

KKR to Sell Novaria Group to Arcline for $2.2 Billion — Neutral

KKR   WSJ — November 10, 2025

The sale comes as private-equity firms are increasing investment in the aerospace and defense sector.

image for news KKR to Sell Novaria Group to Arcline for $2.2 Billion

NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Western Alliance Bancorporation (NYSE: WAL) resulting from allegations that Western Alliance Bancorporation may have issued materially misleading business information to the investing public.

image for news WAL Investor News: If You Have Suffered Losses in Western Alliance Bancorporation (NYSE: WAL), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Buy 3 Ideal Dividend Kings Of 24 'Safer' In November's 56 — Positive

ABM  ADM  ADP  BKH  CBSH  CDUAF  CWT  FRT  FTS  GRC  HRL  HTO  KMB  KO  KVUE  MO  MSEX  NWN  PPG  RLI  SCL  SWK  SYY  TGT  TR   Seeking Alpha — November 10, 2025

The article reviews the November 2025 Dividend Kings, highlighting 56 stocks with long dividend growth records and recent changes to the list. Six Dividend Kings - MO, UVV, HRL, KVUE, CDUAF, UBSI - are currently fairly priced, with annual dividends from $1,000 invested meeting or exceeding share prices. Analyst forecasts suggest top-yielding Kings could deliver net gains of 18.55% to 101.43% by November 2026, with Stepan, H2O America, and National Fuel Gas among the top projections.

image for news Buy 3 Ideal Dividend Kings Of 24 'Safer' In November's 56

Incyte Corporation ( INCY ) Guggenheim Securities 2nd Annual Healthcare Innovation Conference November 10, 2025 10:00 AM EST Company Participants William Meury - CEO, President & Director Pablo Cagnoni - President and Head of Research & Development Conference Call Participants Michael Schmidt - Guggenheim Securities, LLC, Research Division Presentation Michael Schmidt Guggenheim Securities, LLC, Research Division All right. So welcome to this fireside chat with Incyte.

image for news Incyte Corporation (INCY) Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference Transcript

Goodyear Tires: The Wheels Haven't Fallen Off — Negative

GT   Seeking Alpha — November 10, 2025

New management continues to execute the Goodyear Forward Plan. U.S. trade policies provide Goodyear with a competitive financial advantage over international rivals. Temporary issues hinder the operating margins of the industry.

image for news Goodyear Tires: The Wheels Haven't Fallen Off

Outlines Key Initiatives to Reverse Chronic Underperformance, Restore Investor Confidence, Improve Governance, and Drive Value Creation at Cannae

image for news Carronade Capital Issues Investor Presentation Detailing the Need for Change at Cannae Holdings

Tesla board chair Robyn Denholm thanked the electric-vehicle maker's shareholders on Monday for approving CEO Elon Musk's $878 billion pay package.

image for news Tesla chair thanks investors for approving Musk's $878 billion pay package

Visa and MasterCard Strike a Fee Deal. The Winners and Losers. — Neutral

MA  V   Barrons — November 10, 2025

The agreement would allow merchants to lower fees and reject certain credit cards. But what does it mean for the stocks—and shoppers.

image for news Visa and MasterCard Strike a Fee Deal. The Winners and Losers.

New York, New York--(Newsfile Corp. - November 10, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, both dates inclusive (the "Class Period"), of the important December 15, 2025 lead plaintiff deadline. SO WHAT: If you purchased MoonLake common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

image for news ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - MLTX

SAN FRANCISCO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Prominent shareholder rights law firm Hagens Berman is investigating Stride, Inc. (NYSE: LRN), the online education platform, for potential violations of the U.S. securities laws following a series of negative market events and serious fraud allegations that have seen the company's stock price plummet. The firm urges investors in Stride who suffered significant losses to submit your losses now.

image for news Stride, Inc. (LRN) Plunges 49% as Platform Upgrade Fails, Triggering Hagens Berman Probe – Hagens Berman

Exelixis, Inc. ( EXEL ) Guggenheim Securities 2nd Annual Healthcare Innovation Conference November 10, 2025 10:30 AM EST Company Participants Michael Morrissey - CEO, President & Director Conference Call Participants Michael Schmidt - Guggenheim Securities, LLC, Research Division Presentation Michael Schmidt Guggenheim Securities, LLC, Research Division Welcome to this next fireside chat with Exelixis. With us today, we have Mike Morrissey, President and CEO.

image for news Exelixis, Inc. (EXEL) Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference Transcript

Pagaya Technologies Ltd. (PGY) Q3 2025 Earnings Call Transcript — Neutral

PGY   Seeking Alpha — November 10, 2025

Pagaya Technologies Ltd. ( PGY ) Q3 2025 Earnings Call November 10, 2025 8:30 AM EST Company Participants Josh Fagen - Head of Investor Relations & COO of Finance Gal Krubiner - CEO, Co-Founder & Director Sanjiv Das - Co-Founder & President Evangelos Perros - Chief Financial Officer Conference Call Participants John Hecht - Jefferies LLC, Research Division Peter Christiansen - Citigroup Inc., Research Division Harold Goetsch - B.

image for news Pagaya Technologies Ltd. (PGY) Q3 2025 Earnings Call Transcript

YPF Sociedad Anónima (YPF) Q3 2025 Earnings Call Transcript — Neutral

YPF   Seeking Alpha — November 10, 2025

YPF Sociedad Anónima ( YPF ) Q3 2025 Earnings Call November 10, 2025 9:00 AM EST Company Participants Margarita Chun - Investor Relations Officer Horacio Marin - CEO & Non Independent Chairman Maximiliano Westen - Strategy, New Businesses and Controlling Vice President Pedro Kearney - Vice President of Finance Conference Call Participants Alejandro Anibal Demichelis - Jefferies LLC, Research Division Leonardo Marcondes - BofA Securities, Research Division Daniel Guardiola - Banco BTG Pactual S.A., Research Division Guilherme Costa Martins - Goldman Sachs Group, Inc., Research Division Tasso Vasconcellos - UBS Investment Bank, Research Division Presentation Margarita Chun Investor Relations Officer …

image for news YPF Sociedad Anónima (YPF) Q3 2025 Earnings Call Transcript

Repligen Corporation ( RGEN ) UBS Global Healthcare Conference 2025 November 10, 2025 11:00 AM EST Company Participants Jason Garland - CFO & Chief Compliance Officer Jacob Johnson - Vice President of Investor Relations Conference Call Participants Daniel Leonard - UBS Investment Bank, Research Division Presentation Daniel Leonard UBS Investment Bank, Research Division All right. With that, we're ready to kick things off.

image for news Repligen Corporation (RGEN) Presents at UBS Global Healthcare Conference 2025 Transcript

Cogent Biosciences, Inc. ( COGT ) Discusses Positive Phase 3 PEAK Trial Results of Bezuclastinib in Gastrointestinal Stromal Tumors November 10, 2025 8:00 AM EST Company Participants Christi Waarich - Senior Director of Investor Relations Andrew Robbins - President, CEO & Director Conference Call Participants Neeta Somaiah Anupam Rama - JPMorgan Chase & Co, Research Division Paul Jeng - Guggenheim Securities, LLC, Research Division Amanda Acosta-Ruiz - Leerink Partners LLC, Research Division Samuel Slutsky - LifeSci Capital, LLC, Research Division Christopher Raymond - Raymond James & Associates, Inc., Research Division Yuxi Dong - Jefferies LLC, Research Division Presentation Operator Good …

image for news Cogent Biosciences, Inc. (COGT) Discusses Positive Phase 3 PEAK Trial Results of Bezuclastinib in Gastrointestinal Stromal Tumors Transcript

For a company that practically prints cash, Amazon.com Inc. (NASDAQ:AMZN) might soon need Wall Street's help again. The e-commerce and cloud giant has not issued a major bond deal since 2021, when it raised $18.5 billion to fund the MGM acquisition — its last significant borrowing in over four years.

image for news Amazon's $150 Billion AI Capex Surge Could Force Its First Big Bond Deal In Years

MINNEAPOLIS , Nov. 10, 2025 /PRNewswire/ -- Northborne Partners is pleased to announce that it served as financial advisor to Tumac Lumber Company ("Tumac") in connection with the sale of its subsidiary, Disdero Lumber Company ("Disdero"), to BlueLinx Holdings ("BlueLinx"). Founded in 1953 and headquartered in Clackamas, Oregon, Disdero is a leading value-added wholesale distributor of a broad range of premium specialty forest products and other premium building materials used primarily in the construction of custom single-family homes and high-end multi-family residential projects.

image for news Northborne Partners Advises Disdero Lumber Company on its Sale to BlueLinx Holdings

As markets hit highs and AI stocks dominate the headlines, is the rally running on fumes? The Financial Prophet, Victor Dergunov, breaks down the risks of overheated technicals, stretched valuations, and the growing disconnect between Wall Street and the real economy.

image for news Lofty Valuations, Overheated Technicals - Managing Market Risk With Victor Dergunov

NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) for violations of the federal securities laws on behalf of investors who purchased or acquired Baxter securities between February 23, 2022 and July 30, 2025, inclusive (the “Class Period”).

image for news Lowey Dannenberg Notifies Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $250,000 in Losses to Contact the Firm